Literature DB >> 16450137

Molecular imaging of cell transplantation in Parkinson's disease.

Thierry Vander Borght.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16450137     DOI： 10.1007/s00259-005-0041-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  35 in total

Review 1.  Neural transplantation for the treatment of Parkinson's disease.

Authors:  Anders Björklund; Stephen B Dunnett; Patrik Brundin; A Jon Stoessl; Curt R Freed; Robert E Breeze; Marc Levivier; Marc Peschanski; Lorenz Studer; Roger Barker
Journal:  Lancet Neurol       Date:  2003-07       Impact factor: 44.182

Review 2.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

Review 3.  Fetal nigral transplantation as a therapy for Parkinson's disease.

Authors:  C W Olanow; J H Kordower; T B Freeman
Journal:  Trends Neurosci       Date:  1996-03       Impact factor: 13.837

4.  The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat.

Authors:  J M Wilson; S J Kish
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 5.  Strategies for the augmentation of grafted dopamine neuron survival.

Authors:  Caryl E Sortwell
Journal:  Front Biosci       Date:  2003-05-01

Review 6.  Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease.

Authors:  P Hagell; P Brundin
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

7.  The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

Authors:  T Vander Borght; M Kilbourn; T Desmond; D Kuhl; K Frey
Journal:  Eur J Pharmacol       Date:  1995-12-29       Impact factor: 4.432

8.  Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.

Authors:  L Naudon; R Raisman-Vozari; R H Edwards; I Leroux-Nicollet; D Peter; Y Liu; J Costentin
Journal:  Eur J Neurosci       Date:  1996-04       Impact factor: 3.386

9.  Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies.

Authors:  J H Kordower; J M Rosenstein; T J Collier; M A Burke; E Y Chen; J M Li; L Martel; A E Levey; E J Mufson; T B Freeman; C W Olanow
Journal:  J Comp Neurol       Date:  1996-06-24       Impact factor: 3.215

Review 10.  Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.

Authors:  D J Brooks; K A Frey; K L Marek; D Oakes; D Paty; R Prentice; C W Shults; A J Stoessl
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.